Keisuke Ojiro
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Keisuke Ojiro has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Hidetsugu Saito
Division of Gastroenterology and Hepatology, Department of Internal Medicine, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.
2 shared publications - Hirotoshi Ebinuma
Department of Internal Medicine, School of Medicine, Keio University, Tokyo, Japan
2 shared publications - Hideaki Kanamori
Keio University
1 shared publication Kanji Wakabayashi
1 shared publication- Masahiro Kikuchi
Hatanodai Hospital, Japan
1 shared publication - Nobuhiro Nakamoto
Division of Gastroenterology and Hepatology, Department of Internal Medicine Keio University School of Medicine Tokyo Japan
1 shared publication
Latest Publications
- 1 May 2011
- Published by Elsevier in Gastroenterology
- Vol. 140 (5)
MyD88-Dependent Pathway Accelerates the Liver Damage of Concanavalin A-Induced Hepatitis
- 1 May 2011
- Published by Elsevier in Gastroenterology
- Vol. 140 (5)
MyD88-Dependent Pathway Accelerates the Liver Damage of Concanavalin A-Induced Hepatitis
- 17 April 2009
- Published by Springer Nature in Journal of Gastroenterology
- Vol. 44 (6) , 615-623
A new prognostic formula for adult acute liver failure using computer tomography-derived hepatic volumetric analysis
King’s College Hospital (KCH) criteria and the model for end-stage liver disease (MELD) score are useful and widely-employed prognostic markers for acute liver failure (ALF). We previously reported that liver atrophy is an important prognostic factor for ALF. The aim of the present study was to assess the value of liver volumetry and to generate a new prognostic formula. Computed tomography-derived liver volume (CTLV) and standardized liver volume (SLV) of 30 adult ALF patients were calculated at the time of diagnosis. Patients were assigned to one of two groups: group A consisted of 13 patients who recovered without surgical intervention, and group B consisted of 17 patients who died due to liver failure or who underwent living donor liver transplantation (LDLT). The median CTLV/SLV ratios of groups A and B were 1.019 and 0.757, respectively (P = 0.0009). The difference was most significant (P = 0.0002) at the probability cutoff point of 0.80 for CTLV/SLV ratio; the sensitivity and specificity were 76.5% and 92.3%, respectively. Serum total bilirubin (TB) levels and CTLV/SLV ratio were selected as independent prognostic factors by multivariate analysis. A prognostic formula including volumetric analysis was established: Z = −2.3813 − [0.15234 × TB (mg/dl)] + [4.5734 × CTLV/SLV] (AUC = 0.87783, P = 0.0002). The CTLV/SLV ratio is a very useful marker for predicting the prognosis of adult ALF. Our prognostic formula including only the CTLV/SLV ratio and TB is simple and useful and awaits validation in a future larger-scale prospective study.
- 17 April 2009
- Published by Springer Nature in Journal of Gastroenterology
- Vol. 44 (6) , 615-623
A new prognostic formula for adult acute liver failure using computer tomography-derived hepatic volumetric analysis
King’s College Hospital (KCH) criteria and the model for end-stage liver disease (MELD) score are useful and widely-employed prognostic markers for acute liver failure (ALF). We previously reported that liver atrophy is an important prognostic factor for ALF. The aim of the present study was to assess the value of liver volumetry and to generate a new prognostic formula. Computed tomography-derived liver volume (CTLV) and standardized liver volume (SLV) of 30 adult ALF patients were calculated at the time of diagnosis. Patients were assigned to one of two groups: group A consisted of 13 patients who recovered without surgical intervention, and group B consisted of 17 patients who died due to liver failure or who underwent living donor liver transplantation (LDLT). The median CTLV/SLV ratios of groups A and B were 1.019 and 0.757, respectively (P = 0.0009). The difference was most significant (P = 0.0002) at the probability cutoff point of 0.80 for CTLV/SLV ratio; the sensitivity and specificity were 76.5% and 92.3%, respectively. Serum total bilirubin (TB) levels and CTLV/SLV ratio were selected as independent prognostic factors by multivariate analysis. A prognostic formula including volumetric analysis was established: Z = −2.3813 − [0.15234 × TB (mg/dl)] + [4.5734 × CTLV/SLV] (AUC = 0.87783, P = 0.0002). The CTLV/SLV ratio is a very useful marker for predicting the prognosis of adult ALF. Our prognostic formula including only the CTLV/SLV ratio and TB is simple and useful and awaits validation in a future larger-scale prospective study.